Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2017JAMA Psychiatry

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCosima LocherUniversity of BaselHKHelen KoechlinUniversity of ZurichSZSean R. ZionSan Francisco Department of Public Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Locher et al. (2017) studied this question.

synapsesocial.com/papers/6a00a1d26be84a7ac88580b2https://doi.org/10.1001/jamapsychiatry.2017.2432
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The cost of dichotomising continuous variables2006 · 2,716 citations
  2. 2THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES1950 · 1,334 citations
  3. 3A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder2014 · 107 citations
  4. 4Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents2008 · 194 citations